Bluejay Diagnostics announces Board chair and committee chair changes

Bluejay Diagnostics, Inc.

Donald R. Chase appointed Chairperson of the Board, succeeding Douglas C. Wurth.
Douglas C. Wurth appointed Chairperson of Nominating and Corporate Governance Committee, succeeding Fred S. Zeidman.
Fred S. Zeidman appointed Chairperson of Compensation Committee, succeeding Donald R. Chase.
Chase remains Audit Committee Chair; all three independent under Nasdaq rules.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.